Home » Topics » Conferences

Conferences
RSS

Low-dose IL-2 provides benefits in treatment-refractory HCV patients

April 16, 1999

Two gene therapy approaches shown effective in treating hepatocellular carcinoma in rats

April 16, 1999

New taxane analogue shows potential as an orally active alternative to paclitaxel

April 16, 1999

Vion presents parent and prodrug ribonucleotide reductase inhibitors at AACR

April 16, 1999

Jenapharm's scavestrogen is more potent than estrogen in preventing atherosclerosis

April 16, 1999

EntreMed paves the way for clinical evaluation of recombinant human Endostatin

April 16, 1999

Korean researchers report preclinical toxicity and pharmacokinetics of CKD-602 continuous infusion

April 16, 1999

Presence of GHRH receptor is essential for response to treatment with GHRPs

April 16, 1999

In vitro and in vivo profile of AG-7352 described in further detail at AACR meeting

April 16, 1999

Pharmacokinetics and MTD of BBR-2778 determined in cancer patients

April 16, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...